Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases. Intranasal corticosteroids, antihistamines, immunosuppressants, bronchodilators, and leukotriene antagonists are the respiratory medicines that are commonly used for the treatment of mild-to-moderate respiratory diseases. However, the choice of drug depends on the type and severity of the disease.
Technavio's analysts forecast the global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020.
Full Report Details at
- http://www.fastmr.com/prod/1171590_global_resipiratory_drugs.aspx?afid=302
Covered in this report
The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.
The market is divided into the following segments based on geography:
* Americas
* APAC
* EMEA
Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
* AstraZeneca
* Boehringer Ingelheim
* F.Hoffman La-Roche
* GlaxoSmithKline
* Merck
* Novartis
Other prominent vendors
* Abbott
* Actavis
* Afferent Pharmaceuticals
* Alere
* Almirall
* Amgen
* AptarGroup
* Astellas
* Aurobindo
* Axis Shield
* Baxter
* Bayer
* Biogen
* Biotest
* Bristol-Myers Squibb
* Chiesi Farmaceutici
* Cipla
* Cytos
* Dainippon Sumitomo
* Dr. Reddy's Laboratories
* FibroGen
* Gilead Sciences
* Glenmark
* GNI Group Ltd
* Horizon Pharma
* ImmuneWorks
* MediciNova
* MedImmune
* Mylan
* Ono Pharmaceutical
* Orchid Chemicals and Pharmaceuticals
* Perrigo
* Pfizer
* Promedior
* Prometheus
* ProMetic Life Sciences
* Ranbaxy
* Rottapharm Madaus
* Sanofi
* Shionogi
* Siemens Healthcare Diagnostics
* Skyepharma
* Sosei
Sunovion
* Takeda Pharmaceutical
* Teva
* Theravance
* United Therapeutics
* Vectura
* Vertex
* Zai Lab
Market driver
* Rise in prevalence of respiratory diseases
* For a full, detailed list, view our report
Market challenge
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
You may also be interested in these related reports:
- Global Autoimmune Drugs Market 2016-2020
- Global Immunotherapy Drugs 2016-2020
- Global Acne Drugs Market 2016-2020
- Immunotherapy Drugs Market - Global Forecast to 2020
- Global Type 2 Diabetes Market 2016-2020
"Global Resipiratory Drugs Market 2016-2020" Published
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001